Presentation Designed by IBSA laboratories, Profhilo Structura represents a major advancement in aesthetic treatments. This injectable device focuses on tissue restoration and overall firming. Acting deeply, it combats skin laxity while providing a natural lifting effect without the need for surgery.
Composition
& Rheology Active ingredient: High-purity stabilized hyaluronic acid. Concentration: 90 mg per 2 ml syringe (45 mg/ml). Technology: Patented IBSA hybrid complex ensuring even diffusion and prolonged efficacy in the dermis.
Indications
This product is highly recommended for patients with advanced signs of skin aging. It targets loss of density, lack of elasticity, and sagging facial contours. Its bio-restructuring action plumps hollow areas and significantly improves the texture of mature skin. Posology For optimal results, the standard protocol requires two injection sessions, spaced about four weeks apart.
The tightening effect and tissue regeneration develop gradually, revealing their full potential after the second intervention.
Conservation
Store in a dry place, away from direct sunlight and freezing. Follow the temperature guidelines indicated on the original packaging. Contraindications Pregnant or breastfeeding women. Patients with known hypersensitivity to hyaluronic acid. Presence of skin lesions, infections, or inflammation in the treated area. Individuals with unstabilized autoimmune diseases.
FAQ
When are the effects of Profhilo Structura visible? An improvement in hydration is noticeable quickly, but deep restructuring and firming are fully appreciated a few weeks after the second session. Is the treatment painful? Injections are generally well tolerated. The specific diffusion technique developed by IBSA minimizes discomfort during the procedure.
